Surfing the MASH Tsunami

S6 - E7.3 - Deep Dive into Drug Development, Part III: NITs in Drug Development


Listen Later

Send us a text

This conversation is the third segment of SurfingMASH’s April discussion of drug development in memory of Stephen A. Harrison. In addition to co-hosts Jörn Schattenberg, Louise Campbell and Roger Green, panelists include hepatologists and key opinion leaders Sven Francque and Naim Alkhouri. 

Louise starts the discussion by asking when a patient is metabolically and hepatically healthy instead of merely driving weight loss. She notes that basing therapy entirely on weight loss goals will breed failure and frustration while failing to address the actual pivotal goal of metabolic health. Sven agrees and notes how important this point is. Roger suggests that the benefit of weight loss is likely to become limited over time, which is why there is such excitement about GLP-glucagon combination therapies. Again, Sven concurs, noting that such knowledge and increasing drug class diversity will allow researchers to look at true, basic differences between agents instead of "small numerical differences."

Jörn notes the importance of NITs in addressing these kinds of issues. Scanning is an effective method for measuring changes in liver fat; however, the academic community has developed surrogate NITs for specific physiological activities. As Sven notes, there is still a great deal of work to do here. That said, Jörn cites examples of large, NIT-based projects like the VCTE Study Group that have sufficient sample size to start building definitions around kilopascal levels. Louise shares her strong concern that many TE operators are not trained adequately to appreciate subtle clues that would tell an expert how an individual scan was providing misleading results. She notes that the increased demand for scanning, in this case TE, is going to drive a watering down of the qualifications and the skill of the user and the supervision level..." The discussion winds down with Sven agreeing with Louise and stating the need for sequential testing and Jörn citing EASL guidelines in stating that practices should provide and manage high-quality care to the best of their abilities. 

...more
View all episodesView all episodes
Download on the App Store

Surfing the MASH TsunamiBy SurfingNASH.com

  • 3.8
  • 3.8
  • 3.8
  • 3.8
  • 3.8

3.8

23 ratings


More shows like Surfing the MASH Tsunami

View all
JAMA Editors' Summary by JAMA Network

JAMA Editors' Summary

140 Listeners

Planet Money by NPR

Planet Money

30,736 Listeners

Freakonomics Radio by Freakonomics Radio + Stitcher

Freakonomics Radio

32,106 Listeners

The Jesse Chappus Show by Jesse Chappus

The Jesse Chappus Show

1,537 Listeners

Pod Save America by Crooked Media

Pod Save America

86,806 Listeners

The Curbsiders Internal Medicine Podcast by The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

3,337 Listeners

Pod Save the World by Crooked Media

Pod Save the World

24,617 Listeners

The Daily by The New York Times

The Daily

111,160 Listeners

Up First from NPR by NPR

Up First from NPR

55,977 Listeners

Today, Explained by Vox

Today, Explained

10,157 Listeners

The Readout Loud by STAT

The Readout Loud

321 Listeners

The Peter Attia Drive by Peter Attia, MD

The Peter Attia Drive

8,098 Listeners

Docs Who Lift by Docs Who Lift

Docs Who Lift

389 Listeners

The Rest Is Politics: US by Goalhanger

The Rest Is Politics: US

2,197 Listeners

Expose MASH [Formerly NASH] by Novo Nordisk

Expose MASH [Formerly NASH]

10 Listeners